March 28, 2018 / 1:50 PM / a month ago

BRIEF-Guangdong Hybribio Biotech ‍unit receives permission of clinical trial granted by China FDA

March 28 (Reuters) - Guangdong Hybribio Biotech Co Ltd :

* Says its wholly owned unit received permission of clinical trial granted by China FDA with respect to Chloroquine Phosphate Gel

Source text in Chinese: goo.gl/F9hnLQ

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below